PLC Systems of Franklin, MA, has signed an exclusive three-year agreement with Artech of Cavezzo, Italy, to distribute PLC's RenalGuard system in that country.
Artech already has placed an initial order valued at 90,000 euros ($144,000 U.S.) for RenalGuard consoles and accessories to support the initial launch of the system at cardiology centers throughout Italy.
PLC received the CE Mark in December 2007 to market RenalGuard in Europe.
The company concluded a pilot safety trial in the U.S. late last year and has received conditional approval from the U.S. Food and Drug Administration to commence a U.S. trial to study the effectiveness of RenalGuard therapy and the RenalGuard system to prevent contrast-induced nephropathy.
Related Reading
PLC to enroll patients in CIN study, March 21, 2008
PLC Systems unveils CIN prevention technology, September 15, 2006
Copyright © 2008 AuntMinnie.com
![Axial images from unenhanced calcium score cardiac CT (left) and curved planar reformation images from CT angiography (right) show that higher long-term exposure to air pollution is associated with greater coronary artery calcium and more obstructive coronary artery disease (CAD). Top row: Images in a 68-year-old male patient with higher 10-year mean ambient air pollution exposure (7.9 μg/m3 for particulate matter measuring ≤2.5 μm in diameter [PM2.5] and 17.4 parts per billion [ppb] for NO2) with extensive CAD (coronary artery calcium score [CACS] >1,000 and obstructive CAD [≥70% diameter stenosis]). Bottom row: Images in a 57-year-old female patient with lower 10-year mean ambient air pollution exposure (6.3 μg/m3 for PM2.5 and 4.6 ppb for NO2) with no CAD (CACS = 0 and no obstructive stenosis).](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/06/hanneman.r6SMLzkezo.png?auto=format%2Ccompress&dpr=2&fit=crop&h=167&q=70&w=250)
